{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:44:25Z","timestamp":1778712265423,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000890","name":"National MS Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"crossref"}]},{"name":"William Weaver Endowment"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jneuroim.2013.09.009","type":"journal-article","created":{"date-parts":[[2013,10,9]],"date-time":"2013-10-09T21:01:35Z","timestamp":1381352495000},"page":"51-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Activation of NOD2\/RIPK2 pathway induces mitochondrial injury to oligodendrocyte precursor cells in vitro and CNS demyelination in vivo"],"prefix":"10.1016","volume":"265","author":[{"given":"Chandramohan","family":"Natarajan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song-Yi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanglin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subramaniam","family":"Sriram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2013.09.009_bb0005","doi-asserted-by":"crossref","first-page":"38105","DOI":"10.1074\/jbc.R300028200","article-title":"Toll-like receptor signaling","volume":"278","author":"Akira","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0010","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1126\/science.285.5428.736","article-title":"Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2","volume":"285","author":"Aliprantis","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2013.09.009_bb7000","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11010-005-3701-0","article-title":"Inhibition of RIP2\/RIck\/CARDIAK activity by pyridinyl imidazole inhibitors of p38 MAPK","volume":"268","author":"Argast","year":"2005","journal-title":"Mol Cell Biochem."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0015","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ana.21141","article-title":"Environmental risk factors for multiple sclerosis. Part II: noninfectious factors","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuron.2009.09.015","article-title":"Innate and adaptive autoimmunity directed to the central nervous system","volume":"64","author":"Bhat","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0025","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1128\/IAI.00754-10","article-title":"NOD-like receptor activation by outer-membrane vesicles (OMVs) from non-O1 non-O139 Vibrio cholerae is modulated by the quorum sensing regulator HapR","volume":"79","author":"Bielig","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00401-009-0601-5","article-title":"Oligodendrocytes: biology and pathology","volume":"119","author":"Bradl","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0035","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1046\/j.1468-1331.1999.650585.x","article-title":"Increased intrathecal nitric oxide formation in multiple sclerosis; cerebrospinal fluid nitrite as activity marker","volume":"6","author":"Brundin","year":"1999","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0040","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/glia.20473","article-title":"Identification of soluble CD14 as an endogenous agonist for toll-like receptor 2 on human astrocytes by genome-scale functional screening of glial cell derived proteins","volume":"55","author":"Bsibsi","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0045","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/brain\/awf098","article-title":"Prospective study on the relationship between infections and multiple sclerosis exacerbations","volume":"125","author":"Buljevac","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0050","first-page":"3.12.1","article-title":"Purification of oligodendrocytes and their progenitors using immunomagnetic separation and Percoll gradient centrifugation","volume":"Chapter 3","author":"Colello","year":"2001","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0055","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0060","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/jlb.55.5.682","article-title":"Human monocytes\/macrophages: NO or no NO?","volume":"55","author":"Denis","year":"1994","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mam.2004.09.004","article-title":"Nitric oxide and neurological disorders","volume":"26","author":"Duncan","year":"2005","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jneuroim.2010.05.014","article-title":"Orchestrating innate immune responses in multiple sclerosis: molecular players","volume":"225","author":"Fernandez","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0075","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.tips.2005.02.005","article-title":"Mitochondrial nitric oxide synthase","volume":"26","author":"Ghafourifar","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0080","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/135245859800400323","article-title":"The potential role of nitric oxide in multiple sclerosis","volume":"4","author":"Giovannoni","year":"1998","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0085","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0891-5849(02)01298-4","article-title":"Characterization and function of mitochondrial nitric-oxide synthase","volume":"34","author":"Giulivi","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0090","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ana.21800","article-title":"Multiple sclerosis: distribution of inflammatory cells in newly forming lesions","volume":"66","author":"Henderson","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0095","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/glia.22296","article-title":"Microglia are required for astroglial toll-like receptor 4 response and for optimal TLR2 and TLR3 response","volume":"60","author":"Holm","year":"2012","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1023\/A:1020150124721","article-title":"Nitric oxide: a unique endogenous signaling molecule in vascular biology","volume":"19","author":"Ignarro","year":"1999","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0110","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.4049\/jimmunol.175.7.4320","article-title":"TLR signaling tailors innate immune responses in human microglia and astrocytes","volume":"175","author":"Jack","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0105","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/glia.20514","article-title":"Contrasting potential of nitric oxide and peroxynitrite to mediate oligodendrocyte injury in multiple sclerosis","volume":"55","author":"Jack","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0115","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.immuni.2007.10.002","article-title":"Intracellular NOD-like receptors in host defense and disease","volume":"27","author":"Kanneganti","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0120","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.4049\/jimmunol.177.6.4196","article-title":"Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response","volume":"177","author":"Karni","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0125","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cyto.2008.07.010","article-title":"Signalling adaptors used by toll-like receptors: an update","volume":"43","author":"Kenny","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ni0311-199","article-title":"Mitochondrial control of the NLRP3 inflammasome","volume":"12","author":"Kepp","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0891-5849(94)90138-4","article-title":"Peroxynitrite-mediated oxidation of dihydrorhodamine 123","volume":"16","author":"Kooy","year":"1994","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0140","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2990.2011.01189.x","article-title":"The architecture of inflammatory demyelinating lesion in MS: implications for studies on pathogenesis","author":"Lassmann","year":"2011","journal-title":"Neuropathol. Appl. Neurol."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0145","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0165-5728(98)00031-9","article-title":"Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna","volume":"86","author":"Lassmann","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/glia.20928","article-title":"Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury","volume":"58","author":"Lehnardt","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0155","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1365-2990.2008.00987.x","article-title":"Review: mitochondria and disease progression in multiple sclerosis","volume":"34","author":"Mahad","year":"2008","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0160","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/brain\/awn105","article-title":"Mitochondrial defects in acute multiple sclerosis lesions","volume":"131","author":"Mahad","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0165","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/ar2729","article-title":"Toll-like receptors and NOD-like receptors in rheumatic diseases","volume":"11","author":"McCormack","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0170","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ncprheum0802","article-title":"Primer: toll-like receptor signaling pathways \u2014 what do rheumatologists need to know?","volume":"4","author":"O'Neill","year":"2008","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0175","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric oxide and peroxynitrite in health and disease","volume":"87","author":"Pacher","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0180","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.4049\/jimmunol.178.4.2380","article-title":"RICK\/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs","volume":"178","author":"Park","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0185","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2337\/diabetes.50.1.24","article-title":"Serine\/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation","volume":"50","author":"Pederson","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0190","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1172\/JCI58644","article-title":"Innate immunity in the central nervous system","volume":"122","author":"Ransohoff","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0195","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jns.2003.12.011","article-title":"Cerebrospinal fluid nitrite\/nitrate correlated with oxyhemoglobin and outcome in patients with subarachnoid hemorrhage","volume":"219","author":"Rejdak","year":"2004","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0200","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1189\/jlb.1106702","article-title":"Macrophage biology and immunology: man is not a mouse","volume":"81","author":"Schneemann","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0205","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/infdis\/175.1.130","article-title":"Nitrite generation in interleukin-4-treated human macrophage cultures does not involve the nitric oxide synthase pathway","volume":"175","author":"Schneemann","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0210","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/brain\/124.8.1544","article-title":"Bacterial peptidoglycan and immune reactivity in the central nervous system in multiple sclerosis","volume":"124","author":"Schrijver","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0215","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.immuni.2010.12.015","article-title":"Signaling via the RIP2 adaptor protein in central nervous system-infiltrating dendritic cells promotes inflammation and autoimmunity","volume":"34","author":"Shaw","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0225","doi-asserted-by":"crossref","first-page":"22662","DOI":"10.1016\/S0021-9258(18)41723-1","article-title":"Expression and function of IRS-1 in insulin signal transmission","volume":"267","author":"Sun","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0220","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2337\/diabetes.48.7.1359","article-title":"Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway","volume":"48","author":"Sun","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/intimm\/dxh186","article-title":"Toll-like receptors in innate immunity","volume":"17","author":"Takeda","year":"2005","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0235","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1101\/gad.1964410","article-title":"Inhibition of RIP2's tyrosine kinase activity limits NOD2-driven cytokine responses","volume":"24","author":"Tigno-Aranjuez","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0240","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/sj.embor.7400248","article-title":"Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition","volume":"5","author":"Travassos","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0245","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0079-6123(09)17509-X","article-title":"Toll-like receptors in the CNS: implications for neurodegeneration and repair","volume":"175","author":"van Noort","year":"2009","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb6000","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20061704","article-title":"Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide","volume":"404","author":"Windheim","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0250","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.niox.2009.12.001","article-title":"LPS mediated injury to oligodendrocytes is mediated by the activation of nNOS: relevance to human demyelinating disease","volume":"22","author":"Yao","year":"2010","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0260","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jneuroim.2010.07.023","article-title":"In vitro and in vivo induction and activation of nNOS by LPS in oligodendrocytes","volume":"229","author":"Yao","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0255","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.mito.2012.01.002","article-title":"nNOS mediated mitochondrial injury in LPS stimulated oligodendrocytes","volume":"12","author":"Yao","year":"2012","journal-title":"Mitochondrion"},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0270","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/brain\/awm291","article-title":"Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection","volume":"131","author":"Zeis","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0275","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1750-3639.2008.00231.x","article-title":"Molecular changes in white matter adjacent to an active demyelinating lesion in early multiple sclerosis","volume":"19","author":"Zeis","year":"2009","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jneuroim.2013.09.009_bb0280","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/glia.22513","article-title":"Astrogliopathy and oligodendrogliopathy are early events in CNS demyelination","volume":"61","author":"Zhang","year":"2013","journal-title":"Glia"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572813002518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572813002518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:22:47Z","timestamp":1759047767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572813002518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":57,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0165572813002518"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.09.009","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of NOD2\/RIPK2 pathway induces mitochondrial injury to oligodendrocyte precursor cells in vitro and CNS demyelination in vivo","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}